Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up by primary care physicians after hospital discharge.


Clinical Trial Description

Secondary objectives The secondary objective is to assess general practitioners current knowledge and practice of the condition and potential barriers to monitoring and follow-up by general practitioners. Conduct of research Children diagnosed with rheumatoid purpura within the past 2 years at the 3 participating sites will be included in the study if parental authority holders do not object. Patients will be identified through the Medical Information Department of each hospital. Parents will be contacted - first by mail, then by phone - to request permission to collect the child's medical data from medical records, and to retrieve information on the surveillance and follow-up of the disease by general practitioners up to two years after diagnosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05737056
Study type Observational
Source Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Contact
Status Completed
Phase
Start date May 9, 2023
Completion date July 28, 2023

See also
  Status Clinical Trial Phase
Completed NCT04655378 - Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura